Support: 888-992-3836 Home NewsWire Subscriptions
InvestorsHub Logo
Login/Register
Post# of 145
Next 10
Reply Private New
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

whytestocks

Send PM
Followers 119
Posts 15138
Boards Moderated 2
Alias Born 06/04/2018

whytestocks

Re: None

Friday, 11/29/2019 8:00:24 AM

Friday, November 29, 2019 8:00:24 AM

Post# of 145
News: $CYAD Celyad Announces Board of Directors Evolution with New Appointment

Dr. Christian Homsy steps down from the Celyad Board of Directors as current CEO Filippo Petti is nominated into the role MONT-SAINT-GUIBERT, Belgium, Nov. 29, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company f...

In case you are interested CYAD - Celyad Announces Board of Directors Evolution with New Appointment
Public Reply Private Reply New Post
Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CYAD News
More CYAD News
InvestorsHub NewsWire

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • TLSA • Mar 31, 2023 7:07 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news
Only $200 per official company press release!